Lung Cancer Patient Recruitment in North Carolina

TheraNovex connects clinical trial sponsors with pre-screened, eligible Lung Cancer patients across North Carolina, including Charlotte, Raleigh, Greensboro, and beyond.

Lung cancer clinical trial recruitment for NSCLC, SCLC, and mesothelioma studies with rapid pre-screening and enrollment support.

Who qualifies: Adults with non-small cell or small cell lung cancer, including EGFR/ALK/ROS1 mutation-positive patients.

Recruitment challenges: Rapid disease progression requires fast enrollment timelines; molecular subtype matching adds complexity.

Our approach: Pulmonologist and oncologist referral networks, biomarker pre-screening partnerships, and expedited enrollment workflows.

Our recruitment network spans all major metropolitan areas in North Carolina, ensuring broad geographic coverage for your Lung Cancer trial.